Lauren Bullaro Riker Pacira Bio Sciences, Inc. (PCRX) insider trading activity

Lauren Bullaro Riker is Senior Vice President, Finance of Pacira BioSciences, Inc.. Currently has a direct ownership of 38,075 shares of PCRX, which is worth approximately $722,663. The most recent transaction as insider was on Jun 12, 2024, when has been sold 3,970 shares (Common Stock) at a price of $28.72 per share, resulting in proceeds of $114,018. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.1K

0% 3M change

67.83% 12M change

Total Value Held $722,663

Lauren Bullaro Riker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 12 2024	SELL Open market or private sale	$114,018 $28.72 p/Share	3,970 Reduced 9.44%	38,075 Common Stock
Jun 12 2024	BUY Grant, award, or other acquisition	-	21,360 Added 33.69%	42,045 Common Stock
Jun 03 2024	SELL Payment of exercise price or tax liability	$56,930 $30.89 p/Share	1,843 Reduced 8.18%	20,685 Common Stock
Jan 02 2024	SELL Payment of exercise price or tax liability	$5,088 $32.0 p/Share	159 Reduced 0.7%	22,528 Common Stock
Jul 05 2023	SELL Open market or private sale	$25,019 $38.91 p/Share	643 Reduced 2.76%	22,687 Common Stock
Jun 14 2023	SELL Open market or private sale	$244,008 $38.33 p/Share	6,366 Reduced 21.91%	22,687 Common Stock
Jun 14 2023	BUY Grant, award, or other acquisition	-	10,000 Added 25.61%	29,053 Common Stock
Jun 07 2023	SELL Open market or private sale	$23,327 $37.87 p/Share	616 Reduced 3.13%	19,053 Common Stock
Jun 06 2023	SELL Open market or private sale	$23,043 $38.99 p/Share	591 Reduced 2.92%	19,669 Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	-	5,850 Added 22.76%	19,852 Common Stock
Jun 06 2022	SELL Open market or private sale	$70,575 $61.37 p/Share	1,150 Reduced 7.59%	14,002 Common Stock
Mar 10 2022	SELL Open market or private sale	$665,322 $71.54 p/Share	9,300 Reduced 38.03%	15,152 Common Stock
Mar 10 2022	BUY Exercise of conversion of derivative security	$100,533 $10.81 p/Share	9,300 Added 27.55%	24,452 Common Stock
Jan 18 2022	SELL Open market or private sale	$162,425 $64.97 p/Share	2,500 Reduced 14.16%	15,152 Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	$27,025 $10.81 p/Share	2,500 Added 12.41%	17,652 Common Stock
Jan 04 2022	BUY Grant, award, or other acquisition	-	2,000 Added 11.66%	15,152 Common Stock
Jul 29 2021	SELL Open market or private sale	$5,473 $60.81 p/Share	90 Reduced 0.68%	13,152 Common Stock
Jul 29 2021	BUY Exercise of conversion of derivative security	$973 $10.81 p/Share	90 Added 0.68%	13,242 Common Stock
Jul 28 2021	SELL Open market or private sale	$146,648 $60.85 p/Share	2,410 Reduced 15.49%	13,152 Common Stock
Jul 28 2021	BUY Exercise of conversion of derivative security	$26,052 $10.81 p/Share	2,410 Added 13.41%	15,562 Common Stock
Jun 11 2021	SELL Open market or private sale	$119,880 $59.85 p/Share	2,003 Reduced 13.59%	12,731 Common Stock
Jun 09 2021	BUY Grant, award, or other acquisition	-	2,600 Added 15.0%	14,734 Common Stock
Jun 04 2021	SELL Open market or private sale	$63,909 $61.04 p/Share	1,047 Reduced 7.94%	12,134 Common Stock
Mar 17 2021	SELL Open market or private sale	$140,020 $70.01 p/Share	2,000 Reduced 13.17%	13,181 Common Stock
Mar 17 2021	BUY Exercise of conversion of derivative security	$21,620 $10.81 p/Share	2,000 Added 11.64%	15,181 Common Stock

LBR

Lauren Bullaro Riker

Senior Vice President, Finance

Tampa, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Value

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Pacira BioSciences, Inc.

Track Activities on PCRX

Account